Skip to main content
Top
Published in: European Radiology 8/2014

01-08-2014 | Radiological Education

Radiological contrast media in the breastfeeding woman: a position paper of the Italian Society of Radiology (SIRM), the Italian Society of Paediatrics (SIP), the Italian Society of Neonatology (SIN) and the Task Force on Breastfeeding, Ministry of Health, Italy

Authors: Maria Assunta Cova, Fulvio Stacul, Roberto Quaranta, Pierpaolo Guastalla, Guglielmo Salvatori, Giuseppe Banderali, Claudio Fonda, Vincenzo David, Massimo Gregori, Antonio Alberto Zuppa, Riccardo Davanzo

Published in: European Radiology | Issue 8/2014

Login to get access

Abstract

Objectives

Breastfeeding is a well-recognised investment in the health of the mother-infant dyad. Nevertheless, many professionals still advise breastfeeding mothers to temporarily discontinue breastfeeding after contrast media imaging. Therefore, we performed this review to provide health professionals with basic knowledge and skills for appropriate use of contrast media.

Methods

A joint working group of the Italian Society of Radiology (SIRM), Italian Society of Paediatrics (SIP), Italian Society of Neonatology (SIN) and Task Force on Breastfeeding, Ministry of Health, Italy prepared a review of the relevant medical literature on the safety profile of contrast media for the nursing infant/child.

Results

Breastfeeding is safe for the nursing infant of any post-conceptional age after administration of the majority of radiological contrast media to the mother; only gadolinium-based agents considered at high risk of nephrogenic systemic fibrosis (gadopentetate dimeglumine, gadodiamide, gadoversetamide) should be avoided in the breastfeeding woman as a precaution; there is no need to temporarily discontinue breastfeeding or to express and discard breast milk following the administration of contrast media assessed as compatible with breastfeeding.

Conclusions

Breastfeeding women should receive unambiguous professional advice and clear encouragement to continue breastfeeding after imaging with the compatible contrast media.

Key Points:

• Breastfeeding is a well-known investment in the health of the mother-infant dyad.
• Breastfeeding is safe after administration of contrast media to the mother.
• There is no need to temporarily discontinue breastfeeding following administration of contrast media.
Literature
1.
go back to reference Crownover BK, Bepko JL (2013) Appropriate and safe use of diagnostic imaging. Am Fam Physician 87:494–501PubMed Crownover BK, Bepko JL (2013) Appropriate and safe use of diagnostic imaging. Am Fam Physician 87:494–501PubMed
2.
go back to reference Wang PI, Chong ST, Kielar AZ et al (2012) Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations. AJR Am J Roentgenol 198:778–784PubMedCrossRef Wang PI, Chong ST, Kielar AZ et al (2012) Imaging of pregnant and lactating patients: part 1, evidence-based review and recommendations. AJR Am J Roentgenol 198:778–784PubMedCrossRef
3.
go back to reference Frohlich JM, Kubik-Huch RA (2013) Radiographic, MR or ultrasound contrast media in pregnant or breast-feeding women: what are the key issues? Röfo 185:13–25PubMed Frohlich JM, Kubik-Huch RA (2013) Radiographic, MR or ultrasound contrast media in pregnant or breast-feeding women: what are the key issues? Röfo 185:13–25PubMed
5.
go back to reference American Academy of Pediatrics Section on Breastfeeding (2012) Breastfeeding and the use of human milk. Pediatrics 129:e827–e841CrossRef American Academy of Pediatrics Section on Breastfeeding (2012) Breastfeeding and the use of human milk. Pediatrics 129:e827–e841CrossRef
7.
go back to reference Varalda A, Coscia A, Di Nicola P et al (2012) Medication and breastfeeding. J Biol Regul Homeost Agents 26:1–4PubMed Varalda A, Coscia A, Di Nicola P et al (2012) Medication and breastfeeding. J Biol Regul Homeost Agents 26:1–4PubMed
8.
go back to reference Berlin CM Jr, van den Anker JN (2013) Safety during breastfeeding: drugs, foods, environmental chemicals, and maternal infections. Semin Fetal Neonatal Med 18:13–18PubMedCrossRef Berlin CM Jr, van den Anker JN (2013) Safety during breastfeeding: drugs, foods, environmental chemicals, and maternal infections. Semin Fetal Neonatal Med 18:13–18PubMedCrossRef
10.
go back to reference Davanzo R, Rubert L, Oretti C (2008) Meta-variability of advice on drugs in the breastfeeding mother: the example of beta-blockers. Arch Dis Child Fetal Neonatal Ed 93:F249–F250PubMedCrossRef Davanzo R, Rubert L, Oretti C (2008) Meta-variability of advice on drugs in the breastfeeding mother: the example of beta-blockers. Arch Dis Child Fetal Neonatal Ed 93:F249–F250PubMedCrossRef
11.
go back to reference Hale TW (2012) Medications and mothers’ milk 2012, 15th edn. Hale Publishing, Amarillo Hale TW (2012) Medications and mothers’ milk 2012, 15th edn. Hale Publishing, Amarillo
12.
go back to reference Wilson JT, Brown RD, Cherek DR et al (1980) Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences. Clin Pharmacokinet 5:1–66PubMedCrossRef Wilson JT, Brown RD, Cherek DR et al (1980) Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences. Clin Pharmacokinet 5:1–66PubMedCrossRef
19.
go back to reference Webb JAW (2014) Pregnancy and lactation. In: Thomsen HS, Webb JAW (eds) Contrast media: safety issues and ESUR guidelines, 3rd edn. Springer, Berlin Heidelberg Webb JAW (2014) Pregnancy and lactation. In: Thomsen HS, Webb JAW (eds) Contrast media: safety issues and ESUR guidelines, 3rd edn. Springer, Berlin Heidelberg
20.
go back to reference Bourrinet P, Dencausse A, Havard P, Violas X, Bonnemain B (1995) Transplacental passage and milk excretion of iobitridol. Invest Radiol 30:156–158PubMedCrossRef Bourrinet P, Dencausse A, Havard P, Violas X, Bonnemain B (1995) Transplacental passage and milk excretion of iobitridol. Invest Radiol 30:156–158PubMedCrossRef
21.
go back to reference FitzJohn TP, Williams DG, Laker MF, Owen JP (1982) Intravenous urography during lactation. Br J Radiol 55:603–605PubMedCrossRef FitzJohn TP, Williams DG, Laker MF, Owen JP (1982) Intravenous urography during lactation. Br J Radiol 55:603–605PubMedCrossRef
22.
go back to reference Texier F, Roque d'Orbcastel O, Etling N (1983) Stable iodine level in human milk after pulmonary angiography. Presse Med 12:769PubMed Texier F, Roque d'Orbcastel O, Etling N (1983) Stable iodine level in human milk after pulmonary angiography. Presse Med 12:769PubMed
23.
go back to reference Nielsen ST, Matheson I, Rasmussen JN, Skinnemoen K, Andrew E, Hafsahl G (1987) Excretion of iohexol and metrizoate in human breast milk. Acta Radiol 28:523–526PubMedCrossRef Nielsen ST, Matheson I, Rasmussen JN, Skinnemoen K, Andrew E, Hafsahl G (1987) Excretion of iohexol and metrizoate in human breast milk. Acta Radiol 28:523–526PubMedCrossRef
24.
go back to reference Ilett KF, Hackett LP, Paterson JW, McCormick CC (1981) Excretion of metrizamide in milk. Br J Radiol 54:537–538PubMedCrossRef Ilett KF, Hackett LP, Paterson JW, McCormick CC (1981) Excretion of metrizamide in milk. Br J Radiol 54:537–538PubMedCrossRef
26.
go back to reference Johansen JG (1978) Assessment of a non-ionic contrast medium (Amipaque) in the gastrointestinal tract. Invest Radiol 13:523–527PubMedCrossRef Johansen JG (1978) Assessment of a non-ionic contrast medium (Amipaque) in the gastrointestinal tract. Invest Radiol 13:523–527PubMedCrossRef
27.
go back to reference Okazaki O, Murayama N, Masubuchi N, Nomura H, Hakusui H (1996) Placental transfer and milk secretion of gadodiamide injection in rats. Arzneimittelforschung 46:83–86PubMed Okazaki O, Murayama N, Masubuchi N, Nomura H, Hakusui H (1996) Placental transfer and milk secretion of gadodiamide injection in rats. Arzneimittelforschung 46:83–86PubMed
28.
go back to reference Kubik-Huch RA, Gottstein-Aalame NM, Frenzel T et al (2000) Gadopentetate dimeglumine excretion into human breast milk during lactation. Radiology 216:555–558PubMedCrossRef Kubik-Huch RA, Gottstein-Aalame NM, Frenzel T et al (2000) Gadopentetate dimeglumine excretion into human breast milk during lactation. Radiology 216:555–558PubMedCrossRef
29.
go back to reference Schmiedl U, Maravilla KR, Gerlach R, Dowling CA (1990) Excretion of gadopentetate dimeglumine in human breast milk. AJR Am J Roentgenol 154:1305–1306PubMedCrossRef Schmiedl U, Maravilla KR, Gerlach R, Dowling CA (1990) Excretion of gadopentetate dimeglumine in human breast milk. AJR Am J Roentgenol 154:1305–1306PubMedCrossRef
30.
go back to reference Rofsky NM, Weinreb JC, Litt AW (1993) Quantitative analysis of gadopentetate dimeglumine excreted in breast milk. J Magn Reson Imaging 3:131–132PubMedCrossRef Rofsky NM, Weinreb JC, Litt AW (1993) Quantitative analysis of gadopentetate dimeglumine excreted in breast milk. J Magn Reson Imaging 3:131–132PubMedCrossRef
31.
go back to reference Kaminsky S, Laniado M, Gogoll M et al (1991) Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy. Radiology 178:503–508PubMed Kaminsky S, Laniado M, Gogoll M et al (1991) Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy. Radiology 178:503–508PubMed
32.
go back to reference Laniado M, Kornmesser W, Hamm B, Clauss W, Weinmann HJ, Felix R (1988) MR imaging of the gastrointestinal tract: value of Gd-DTPA. AJR Am J Roentgenol 150:817–821PubMedCrossRef Laniado M, Kornmesser W, Hamm B, Clauss W, Weinmann HJ, Felix R (1988) MR imaging of the gastrointestinal tract: value of Gd-DTPA. AJR Am J Roentgenol 150:817–821PubMedCrossRef
33.
go back to reference Idee JM, Port M, Raynal I, Schaefer M, Le Greneur S, Corot C (2006) Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 20:563–576PubMedCrossRef Idee JM, Port M, Raynal I, Schaefer M, Le Greneur S, Corot C (2006) Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 20:563–576PubMedCrossRef
34.
go back to reference Tweedle MF, Wedeking P, Kumar K (1995) Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats. Invest Radiol 30:372–380PubMedCrossRef Tweedle MF, Wedeking P, Kumar K (1995) Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats. Invest Radiol 30:372–380PubMedCrossRef
35.
go back to reference White GW, Gibby WA, Tweedle MF (2006) Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Invest Radiol 41:272–278PubMedCrossRef White GW, Gibby WA, Tweedle MF (2006) Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Invest Radiol 41:272–278PubMedCrossRef
36.
go back to reference Abraham JL, Thakral C (2008) Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis. Eur J Radiol 66:200–207PubMedCrossRef Abraham JL, Thakral C (2008) Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis. Eur J Radiol 66:200–207PubMedCrossRef
37.
go back to reference Webb JAW, Thomsen HS (2013) Gadolinium contrast media during pregnancy and lactation. Acta Radiol 54:599–600PubMedCrossRef Webb JAW, Thomsen HS (2013) Gadolinium contrast media during pregnancy and lactation. Acta Radiol 54:599–600PubMedCrossRef
38.
go back to reference Claudon M, Dietrich CF, Choi BI et al (2013) Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver—update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 39:187–210PubMedCrossRef Claudon M, Dietrich CF, Choi BI et al (2013) Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver—update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 39:187–210PubMedCrossRef
39.
go back to reference Senthilnathan S, Gauvreau K, Marshall AC, Lock JE, Bergersen L (2009) Contrast administration in pediatric cardiac catheterization: dose and adverse events. Catheter Cardiovasc Interv 73:814–820PubMedCrossRef Senthilnathan S, Gauvreau K, Marshall AC, Lock JE, Bergersen L (2009) Contrast administration in pediatric cardiac catheterization: dose and adverse events. Catheter Cardiovasc Interv 73:814–820PubMedCrossRef
40.
41.
go back to reference Callahan MJ, Poznauskis L, Zurakowski D, Taylor GA (2009) Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban children's hospital—retrospective analysis of data in 12,494 patients. Radiology 250:674–681PubMedCrossRef Callahan MJ, Poznauskis L, Zurakowski D, Taylor GA (2009) Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban children's hospital—retrospective analysis of data in 12,494 patients. Radiology 250:674–681PubMedCrossRef
43.
go back to reference Thomsen HS, Morcos SK, Almen T et al (2013) Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 23:307–318PubMedCrossRef Thomsen HS, Morcos SK, Almen T et al (2013) Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 23:307–318PubMedCrossRef
44.
go back to reference Bernstein EJ, Schmidt-Lauber C, Kay J (2012) Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure. Best Pract Res Clin Rheumatol 26:489–503PubMedCrossRef Bernstein EJ, Schmidt-Lauber C, Kay J (2012) Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure. Best Pract Res Clin Rheumatol 26:489–503PubMedCrossRef
45.
go back to reference Nardone B, Saddleton E, Laumann AE et al (2014) Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report. Pediatr Radiol 44:173–180PubMedCrossRef Nardone B, Saddleton E, Laumann AE et al (2014) Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report. Pediatr Radiol 44:173–180PubMedCrossRef
46.
go back to reference Schneider G, Schurholz H, Kirchin MA, Bucker A, Fries P (2013) Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children. Pediatr Radiol 43:202–211PubMedCrossRef Schneider G, Schurholz H, Kirchin MA, Bucker A, Fries P (2013) Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children. Pediatr Radiol 43:202–211PubMedCrossRef
47.
go back to reference Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC (2007) Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults. AJR Am J Roentgenol 189:1533–1538PubMedCrossRef Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC (2007) Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults. AJR Am J Roentgenol 189:1533–1538PubMedCrossRef
49.
go back to reference Hylton NM (2000) Suspension of breast-feeding following gadopentetate dimeglumine administration. Radiology 216:325–326PubMedCrossRef Hylton NM (2000) Suspension of breast-feeding following gadopentetate dimeglumine administration. Radiology 216:325–326PubMedCrossRef
50.
go back to reference Chen MM, Coakley FV, Kaimal A, Laros RK Jr (2008) Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol 112:333–340PubMedCrossRef Chen MM, Coakley FV, Kaimal A, Laros RK Jr (2008) Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol 112:333–340PubMedCrossRef
51.
go back to reference Webb JA, Thomsen HS, Morcos SK (2005) The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 15:1234–1240PubMedCrossRef Webb JA, Thomsen HS, Morcos SK (2005) The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 15:1234–1240PubMedCrossRef
52.
go back to reference Tremblay E, Therasse E, Thomassin-Naggara I, Trop I (2012) Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation. Radiographics 32:897–911PubMedCrossRef Tremblay E, Therasse E, Thomassin-Naggara I, Trop I (2012) Quality initiatives: guidelines for use of medical imaging during pregnancy and lactation. Radiographics 32:897–911PubMedCrossRef
53.
go back to reference Sachs HC (2013) The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics 132:e796–e809PubMedCrossRef Sachs HC (2013) The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics 132:e796–e809PubMedCrossRef
Metadata
Title
Radiological contrast media in the breastfeeding woman: a position paper of the Italian Society of Radiology (SIRM), the Italian Society of Paediatrics (SIP), the Italian Society of Neonatology (SIN) and the Task Force on Breastfeeding, Ministry of Health, Italy
Authors
Maria Assunta Cova
Fulvio Stacul
Roberto Quaranta
Pierpaolo Guastalla
Guglielmo Salvatori
Giuseppe Banderali
Claudio Fonda
Vincenzo David
Massimo Gregori
Antonio Alberto Zuppa
Riccardo Davanzo
Publication date
01-08-2014
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 8/2014
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3198-6

Other articles of this Issue 8/2014

European Radiology 8/2014 Go to the issue